Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant

NCT04933968 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

17

Enrollment

INDUSTRY

Sponsor class

Stopped Strategic sponsor decision

Conditions

Respiratory Tract Viral Infections
Human Metapneumovirus (hMPV) Infection
Parainfluenza (PIV) Infection
Respiratory Syncytial Viral (RSV) Infection
Influenza Infection

Interventions

BIOLOGICAL: ALVR106
BIOLOGICAL: Placebo

Sponsor

AlloVir